Patrys Ltd has released a press release.
PAT DX3 Crosses Blood Brain Barrier in Healthy Animals
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Patrys
- Appendix 4E and 2022 Annual Report
- PAT-DX1 From Engineering Run Meets all Specification Tests
- New Research Grant For Deoxymabs in Metastatic Breast Cancer
- PAT-DX1/Radiation Combination Improves Brain Cancer Survival
- Appendix 4C - Quarterly - 30 June 2022
Later from Patrys
- Appendix 4C - Quarterly - 30 September 2022
- Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy
- Response to ASX Price Query
- Appendix 4C - Quarterly - 31 December 2022
- Appendix 4D - Half Year Accounts - 31 December 2022
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys